Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5825621 | Clinical Therapeutics | 2013 | 18 Pages |
Abstract
We found that ASA plus DP was more protective than ASA alone for preventing recurrent stroke; however, no difference was found between most direct and indirect comparisons of antiplatelet agents and combinations. More overall hemorrhagic events seemed to occur with the combination of ASA and clopidogrel than with other treatments. Selection of antiplatelet therapy for the secondary prevention of stroke must be individualized according to patient comorbidities, including risk of stroke recurrence and bleeding.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Rhynn J. PharmD, Abir O. PharmD, Matthew A. PharmD, BCPS, Jennifer L. PharmD,